ConductScience.org, home

Paper6328152

Age-related modification of dopaminergic and beta-Adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosylmethionine.

Cimino M and 5 others. Life Sci, 1984. Cited by 115 papers, by iCite.

Cite this record

ConductScience Library. Age-related modification of dopaminergic and beta-Adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosylmethionine. Papers, record 6328152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6328152

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Age-related modification of dopaminergic and beta-Adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosylmethionine.
PubMed
Journal
Life Sci
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
5.28
iCite
Revised in PubMed
2019-07-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cimino MM
2Vantini GG
3Algeri SS
4Curatola GG
5Pezzoli CC
6Stramentinoli GG

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cerebral CortexMajor topic
Corpus StriatumMajor topic
Membrane FluidityMajor topic
Receptors, Adrenergic, betaMajor topic
Receptors, DopamineMajor topic
S-AdenosylmethionineMajor topic
Aging
Animals
Cell Membrane
Dihydroalprenolol
Kinetics
Phospholipids
Rats
Spiperone

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
39203943Targeting Divergent Pathways in the Nutritional Management of Depression.Nutrients2024https://conductscience.org/library/papers/39203943PubMed
38590512(S)-S-adenosylmethionine in the treatment of pre-menstrual disorders in adult women: A protocol for an open-label pilot study.Contemp Clin Trials Commun2024https://conductscience.org/library/papers/38590512PubMed
28682528S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.J Clin Psychiatry2017https://conductscience.org/library/papers/28682528PubMed
23111116Enhancing the production of S-adenosyl-L-methionine in Pichia pastoris GS115 by metabolic engineering.AMB Express2012https://conductscience.org/library/papers/23111116PubMed
15644997The effect of methionine and S-adenosylmethionine on S-adenosylmethionine levels in the rat brain.J Psychiatry Neurosci2005https://conductscience.org/library/papers/15644997PubMed
10401554Influence of S-adenosyl-L-methionine on chronic mild stress-induced anhedonia in castrated rats.Br J Pharmacol1999https://conductscience.org/library/papers/10401554PubMed
9118813Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.Drugs1996https://conductscience.org/library/papers/9118813PubMed
8297922The use of diet and dietary components in the study of factors controlling affect in humans: a review.J Psychiatry Neurosci1993https://conductscience.org/library/papers/8297922PubMed
7957769The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice.Experientia1994https://conductscience.org/library/papers/7957769PubMed
7527320The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.Drugs1994https://conductscience.org/library/papers/7527320PubMed
6489422Pharmacokinetics of S-adenosyl-L-methionine in healthy volunteers.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6489422PubMed
2804550Vasodilator responses to dopamine in rat perfused mesentery are age-dependent.Br J Pharmacol1989https://conductscience.org/library/papers/2804550PubMed
2680435S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.Drugs1989https://conductscience.org/library/papers/2680435PubMed
1665371Beta-adrenergic function in aging. Basic mechanisms and clinical implications.Drugs Aging1991https://conductscience.org/library/papers/1665371PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6328152

GET https://conductscience.org/api/papers/v1/6328152/authors